![IJERPH | Free Full-Text | Racism and Cancer Screening among Low-Income, African American Women: A Multilevel, Longitudinal Analysis of 2-1-1 Texas Callers IJERPH | Free Full-Text | Racism and Cancer Screening among Low-Income, African American Women: A Multilevel, Longitudinal Analysis of 2-1-1 Texas Callers](https://www.mdpi.com/ijerph/ijerph-18-11267/article_deploy/html/images/ijerph-18-11267-g001.png)
IJERPH | Free Full-Text | Racism and Cancer Screening among Low-Income, African American Women: A Multilevel, Longitudinal Analysis of 2-1-1 Texas Callers
![Cancers | Free Full-Text | Impact of Lung Metastasis versus Metastasis of Bone, Brain, or Liver on Overall Survival and Thyroid Cancer-Specific Survival of Thyroid Cancer Patients: A Population-Based Study Cancers | Free Full-Text | Impact of Lung Metastasis versus Metastasis of Bone, Brain, or Liver on Overall Survival and Thyroid Cancer-Specific Survival of Thyroid Cancer Patients: A Population-Based Study](https://pub.mdpi-res.com/cancers/cancers-14-03133/article_deploy/html/images/cancers-14-03133-g001-550.jpg?1656401284)
Cancers | Free Full-Text | Impact of Lung Metastasis versus Metastasis of Bone, Brain, or Liver on Overall Survival and Thyroid Cancer-Specific Survival of Thyroid Cancer Patients: A Population-Based Study
![41st Annual Meeting of the Society for Medical Decision Making, Portland, Oregon, October 20–23, 2019, 2020 41st Annual Meeting of the Society for Medical Decision Making, Portland, Oregon, October 20–23, 2019, 2020](https://journals.sagepub.com/cms/10.1177/0272989X19890544/asset/images/large/10.1177_0272989x19890544-fig81.jpeg)
41st Annual Meeting of the Society for Medical Decision Making, Portland, Oregon, October 20–23, 2019, 2020
![Cancers | Free Full-Text | Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular Cancers | Free Full-Text | Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular](https://www.mdpi.com/cancers/cancers-14-04649/article_deploy/html/images/cancers-14-04649-g001.png)